The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders

Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M. Gittelman, Heidi Chapman, John C. Prostko, Edwin C. Frias, James L. Stewart, Valeriya Pozdnyakova, Philip Debbas, Angela Mujukian, Arash A Horizon, Noah Merin, Sandy Joung, Gregory J. Botwin, Kimia Sobhani, Jane C. Figueiredo, Susan Cheng, Ian M. Kaplan, Dermot P.B. McGovern, Akil Merchant, Gil Y. Melmed, Jonathan Braun
doi: https://doi.org/10.1101/2021.12.08.21267444

Article usage

Article usage: December 2021 to October 2024

AbstractFullPdf
Dec 2021183018288
Jan 20223621381
Feb 2022236460
Mar 2022106431
Apr 2022140255
May 202283052
Jun 2022771724
Jul 202276625
Aug 202271222
Sep 2022144226
Oct 202253015
Nov 202256024
Dec 202245115
Jan 202387213
Feb 202330313
Mar 20232608
Apr 20232537
May 20232429
Jun 20232046
Jul 2023824
Aug 202318136
Sep 20232158
Oct 202335218
Nov 20232425
Dec 20232217
Jan 20241744
Feb 20241537
Mar 202423112
Apr 202421414
May 202424213
Jun 202431314
Jul 20242829
Aug 202430516
Sep 20242125
Oct 202425102
Back to top
Posted December 08, 2021.
Download PDF
Data/Code
Email
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M. Gittelman, Heidi Chapman, John C. Prostko, Edwin C. Frias, James L. Stewart, Valeriya Pozdnyakova, Philip Debbas, Angela Mujukian, Arash A Horizon, Noah Merin, Sandy Joung, Gregory J. Botwin, Kimia Sobhani, Jane C. Figueiredo, Susan Cheng, Ian M. Kaplan, Dermot P.B. McGovern, Akil Merchant, Gil Y. Melmed, Jonathan Braun
medRxiv 2021.12.08.21267444; doi: https://doi.org/10.1101/2021.12.08.21267444
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area